Spain-based consultancy Hempire Labs has expanded its EU GMP facility design services, supporting licensed medical cannabis producers in building regulatory-ready cultivation facilities from the ground up.
-- Hempire Labs, a Spain-based consultancy specializing in medical cannabis facility design and regulatory compliance, has expanded its services to address growing demand from licensed producers seeking integrated support across cultivation planning and pharmaceutical infrastructure. The firm helps operators work through critical design factors before construction begins — facility layout, environmental controls, workflow planning, documentation systems, and regulatory readiness — to reduce the risk of costly compliance issues further down the line.
More details can be found at https://hempirelabs.com
The stakes for upfront planning in this sector continue to grow. The International Society for Pharmaceutical Engineering (ISPE) has long emphasized through its Baseline Guides that facility design decisions made in the earliest stages have a direct bearing on contamination control, operational efficiency, and long-term regulatory compliance. Medical cannabis cultivation facilities with design-related deficiencies risk failing regulatory inspections, which can trigger costly redesigns and push commercial launch back by six months or more.
To address these challenges, Hempire Labs provides consulting that integrates Good Agricultural and Collection Practice (GACP) requirements into facility planning while considering downstream Good Manufacturing Practice (GMP) and Good Distribution Practice (GDP) expectations.
"Medical cannabis cultivation facilities are no longer designed solely around production capacity," said a Hempire Labs spokesperson. "They must also support long-term regulatory compliance and future pharmaceutical manufacturing requirements. Integrating regulatory considerations during the design phase helps operators avoid preventable setbacks while building facilities that are better prepared for inspection and future expansion."
The consultancy notes that its expanded service supports businesses through facility planning, design review, project development, regulatory preparation, and quality-focused infrastructure strategies that help establish compliant cultivation facilities capable of supporting future pharmaceutical manufacturing operations.
Hempire Labs says its approach brings together cultivation workflows, cleanroom planning, contamination control strategies, and quality management principles within a scalable facility layout — helping operators prepare for regulatory inspections while building infrastructure that supports long-term operational efficiency.
About Hempire Labs
Founded in 2019 in Sotogrande, Spain, Hempire Labs is a medical cannabis facility design and regulatory consulting firm. Established by medical cannabis consultant Mardi Joubanian and Paulina Molyneux-Webb, a project management professional with pharmaceutical industry experience, the company assists licensed producers worldwide in developing GACP-, GMP-, and GDP-compliant facilities for cultivation, extraction, processing, and pharmaceutical manufacturing.
Licensed producers and businesses planning a medical cannabis cultivation facility can find more information by visiting https://hempirelabs.com
Contact Info:
Name: Paulina Molyneux-Webb
Email: Send Email
Organization: Hempire Labs S.L.
Address: C.C., Mar y Sol Local 3.9, Sotogrande, Andalucía 11310, Spain
Website: https://hempirelabs.com
Source: NewsNetwork
Release ID: 89205686
If there are any problems, discrepancies, or queries related to the content presented in this press release, we kindly ask that you notify us immediately at error@releasecontact.com (it is important to note that this email is the authorized channel for such matters, sending multiple emails to multiple addresses does not necessarily help expedite your request). Our responsive team will be available round-the-clock to address your concerns within 8 hours and take necessary actions to rectify any identified issues or support you with press release takedowns. Ensuring accurate and trustworthy information is our unwavering commitment.
